MONICA TRIPODI: Open Payments
NPI 1356808182 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 58 payments from 26 companies in 2025. Trend: 2023 $2,626 · 2024 $3,802 · 2025 $1,435
Food & beverage: $1,391Education: $44
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $133 |
| Janssen Biotech, Inc. | 4 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| Incyte Corporation | 4 | $101 |
| Gilead Sciences, Inc. | 3 | $85 |
| ABBVIE INC. | 3 | $80 |
| ARRAY BIOPHARMA INC | 3 | $74 |
| Celgene Corporation | 3 | $72 |
| GENZYME CORPORATION | 3 | $72 |
| Astellas Pharma US Inc | 2 | $64 |
Products named: VERZENIO, Trodelvy, CARVYKTI, REBLOZYL, KEYTRUDA, AYVAKIT, JAKAFI, MONJUVI.
Industry payments across TX — which companies pay providers there.
